During PRRT, SSTR2 on the tumor cell surface is targeted by the somatostatin analog DOTA-TATE, after which the coupled radionuclide lutetium-177 locally induces DNA damage after radioactive decay [11]. Here, SSTR2 is linked to neoplasm.